What they were paid
Akero Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $60,000 | $0 | $434,632 | $0 | $494,632 |
| FY2023 | $60,000 | — | $521,064 | — | $581,064 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Akero Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0000950170-25-058964, and prior-year filings. Open the filing on EDGAR.
Committees
FY2024 · as the proxy prints themAudit · Nominating/Governance (Chair)
The rest of the Akero Therapeutics board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Andrew Cheng | Director | $0 |
| Graham L. Walmsley | Independent Director | $492,132 |
| Jane Henderson | Independent Director | $499,632 |
| Judy Chou | Independent Director | $484,632 |
| Mark T. Iwicki | Chair of the Board | $519,632 |
| Seth L. Harrison | Independent Director | $478,382 |
| Yuan Xu | Independent Director | $487,132 |
The full Akero Therapeutics compensation record
free company briefThis page is one director within Akero Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat